Leiden – MIMETAS, a global leader in human disease modeling announces that it has entered into a strategic partnership with Astellas Pharma Inc., a global pharmaceutical company. The partnership comprises utilizing MIMETAS’ comprehensive tumor models to support the next generation of immuno-oncological therapies. “We are excited to make this next step in our longstanding collaboration with […]

GeminiBio opens new cGMP bioprocess liquid manufacturing facility, expanding capabilities to better serve the biotechnology and cell & gene therapy markets WEST SACRAMENTO, Calif. ‐‐ Gemini Bioproducts, LLC (“GeminiBio”), a leading manufacturer of cell culture products and custom cGMP bioprocess liquids for the biotech industry and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a Ft. Lauderdale, Florida based healthcare private equity firm, today announced the opening of a new, state‐of‐the‐art cGMP bioprocess liquid […]

New products will accelerate the adoption and scalability of groundbreaking translational and clinical research LAUSANNE, Switzerland – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the launch of a full expansion of its product offering to provide a universal, end-to-end spatial biology solution, answering the needs of the […]

TileDB database first to implement an open data model and API specification, enabling rapid cloud-optimized analysis of large single-cell datasets CAMBRIDGE, Mass. — TileDB, the database for any complex data and compute, today announced the launch of TileDB–SOMA, the first collection of software libraries that implement the open-source SOMA API specification. SOMA and TileDB-SOMA are the result […]

SAN CARLOS, Calif. — Factorial Biotechnologies, an emerging single-cell sequencing company with a novel intracellular library preparation technology, has announced a collaboration with Watchmaker Genomics, a life sciences company that specializes in developing high-stringency applications for reading, writing, and editing of DNA and RNA. This collaboration will focus on further optimizing a disruptive technology that enables […]

Collaboration will enable members to leverage the Tapestri® single-cell technology to streamline cell therapy development and manufacturing processes SOUTH SAN FRANCISCO, CA – Mission Bio, the pioneer in high-throughput single-cell DNA and multi-omics analysis, has joined the National Science Foundation (NSF) Engineering Research Center for Cell Manufacturing Technologies (CMaT), leveraging its Tapestri® Platform to improve analytical […]

New England Biolabs® (NEB®) – a global leader in the discovery and production of enzymes for molecular biology applications – has announced it is establishing its first overseas product development and manufacturing site at Milton Park, one of the UK’s leading life science clusters. NEB Lyophilization Sciences™ is a wholly owned subsidiary of NEB and […]

Target single and double sanction badge users Expected effectiveness of covering various types of cell culture media Ajinomoto Genexine’s cell culture medium brand CELLiST (CELLiST) announced on the 24th that it has launched ‘AminoSupplement Cys1/Cys2’. CELLiST plans to construct and supply a product lineup that can cover various types of cell culture media by dividing […]

ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and to support innovative, cell-based research, today announced Douglas J. Swirsky has been appointed as the Company’s Chief Financial Officer, effective immediately. Mr. Swirsky is a […]

WALTHAM, Mass. & SAN FRANCISCO — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat conditions, including cancer, rare diseases, and other illnesses, from a newly opened cGMP manufacturing facility adjacent to UCSF Medical Center’s […]